CareFusion is a new medical-technology company that is currently a wholly owned subsidiary of Cardinal Health (NYSE:CAH). We are expected to become a separate publicly traded company from the planned spinoff of Cardinal Health's clinical and medical products businesses.
Cardinal Health expects to complete the spinoff by distributing to its shareholders on a pro rata basis at least 80% of the outstanding shares of CareFusion common stock, in a manner that is intended to be tax-free. Additional information regarding CareFusion and the planned spinoff can be found in the registration statement on Form 10 filed by CareFusion with the U.S. Securities and Exchange Commission.
Shareholders of Cardinal Health that have questions regarding their shares can also obtain information by clicking here.
Cautions Concerning Forward-Looking Statements: This website contains forward-looking statements addressing the planned spinoff of Cardinal Health’s clinical and medical products businesses as a separate company named CareFusion Corporation, which is dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of any such spinoff and whether such spinoff will be completed as it is subject to a number of conditions. In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion’s Form 10, as amended, and Cardinal Health’s Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.
